Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;40(4):407-411.
doi: 10.1080/08880018.2022.2101722. Epub 2022 Jul 21.

Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor

Rachel D Harris  1   2 , Melissa A Richard  1   2 , Maria Monica J Gramatges  1   2 , Kevin Wilhelm  1 , Michael E Scheurer  1   2 , Philip J Lupo  1   2 , Austin L Brown  1   2
Affiliations

Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor

Rachel D Harris et al. Pediatr Hematol Oncol. 2023 May.

Abstract

Survivors of childhood central nervous system (CNS) tumors experience early-onset aging-related phenotypes. DNA methylation (DNAm) age is an emerging epigenetic biomarker of physiologic age and may be predictive of chronic health conditions in long-term survivors. This report describes the course of epigenetic age acceleration using post-diagnosis blood samples (median: 3.9 years post-diagnosis; range: 0.04-15.96) from 83 survivors of pediatric CNS tumors. Epigenetic age acceleration was detected in 72% of patients, with an average difference between chronologic and DNAm age of 2.58 years (95% CI: 1.75-3.41, p < 0.001). Time from diagnosis to sample collection correlated with the magnitude of epigenetic age acceleration.

Keywords: Epigenetics; PNET; aging; medulloblastoma; survivorship.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
(A) DNAm age and chronological age of all participants with linear trend line. (B) Boxplots showing distribution of epigenetic age acceleration over time since diagnosis.
See this image and copyright information in PMC

References

    1. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. doi: 10.3322/caac.21219. - DOI - PubMed
    1. Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol. 2008;65(11):1419–1424. doi: 10.1001/archneur.65.11.1419. - DOI - PubMed
    1. Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101(13):946–958. doi: 10.1093/jnci/djp148. - DOI - PMC - PubMed
    1. Ness KK, Krull KR, Jones KE, et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol. 2013;31(36):4496–4503. doi: 10.1200/JCO.2013.52.2268. - DOI - PMC - PubMed
    1. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582. doi: 10.1056/NEJMsa060185. - DOI - PubMed

MeSH terms

LinkOut - more resources